About Quro Pipeline Organization News ContactHome Site Map INNOVATION IN INFECTIOUS DISEASES TREATMENT

About Quro Pipeline Organization News Contact Home Site Map

INNOVATION IN INFECTIOUS DISEASES TREATMENT


Quro Science Inc.

Quro is a spin-off biotechnology company from Institut Pasteur Korea (IP-K) committed to develop novel therapeutics against infectious diseases. Quro’s main focus is on human immunodeficiency virus (HIV), hepatitis C virus (HCV) and tuberculosis (TB) infection. Quro has exclusive rights to develop and commercialize drug candidates discovered with IP-K’s proprietary state-of-the-art technologies including the PhenomicScreenTM and PhenomicIDTM platforms. Quro has in-house expertise in preclinical and clinical development management and operates as a virtual company using contract research organizations (CROs) for execution of the development works. Quro intends to license out the products in the course of the clinical development to larger partners for further development.


Quro’s Operations Model




Organizational Chart


Management Team

Dr. Ulf Nehrbass, CEODr. Nehrbass graduated in Biochemistry from Cambridge University, UK, and obtained his Ph.D. at the EMBL in Heidelberg, Germany in 1992. After a postdoctoral position in the Howard Hughes Medical Institute at the Rockefeller University, New York, he joined the Institut Pasteur in Paris, in 1998 where he was Head of the Nuclear Cell Biology unit and CNRS Research Director. After a number of research awards he was elected member of EMBO in 2005. He has been CEO of IP-Korea since its inception in 2004.


Board of Directors

Dr. Ulf NehrbassHead of the Nuclear Cell Biology unit, Institut Pasteur in ParisCNRS Research DirectorCEO of Institut Pasteur Korea

Dr. Yung Bog Chae Chairman of Institut Pasteur Korea Board of Directors Chairman of Gyeonggi Bio-CenterFormer Minister, Ministry of Science and Technology, Republic of Korea

Mr. Seok Won Yoon General Manager, Hanwha Venture Capital Corp.Director, Green & Biotech, Inc.General Manager, Basic Venture Capital, Co., Ltd


Board of Directors

Dr. Yongmo LeeDirector, Center for International Cooperation, National Research FoundationAssociate Professor,

Dr. Myung Whan Park Director of Gyeonggi Bio-Center

Dr. Jae Whan Park Professor, Department of Business and Management SchoolOf Social Science, Chung-Ang University

External Auditor


Bulletin board here


Quro Science Inc.Sampyeong-dong 696 Bundang-gu Seongnam-si Gyeonggi-do, Korea Tel: +82-31-8018-8370Fax: [email protected]

Quro Science Inc.Sampyeong-dong 696 Bundang-gu Seongnam-si Gyeonggi-do, Korea Tel: +82-31-8018-8370Fax: [email protected]

Documents

About Quro Pipeline Organization News ContactHome Site Map INNOVATION IN INFECTIOUS DISEASES TREATMENT